alexa Economics Of Implementing International Standard Effective Population Based Cervical Cancer Screening In India: A Pan India Study
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

3rd International Conference and Exhibition on Pathology
April 14-15, 2014 Hilton San Antonio Airport, TX, USA

Manu Noatay
ScientificTracks Abstracts: J Clin Exp Pathol
DOI: 10.4172/2161-0681.S1.012
To develop an effective population based screening programme for cervical cancer detection as there is a lack of effective organised screening programs for cervical cancer. Cervical Cancer (Cervix Uteri) is the most common form of Cancer among women in India. India has a population of 366.58 million women ages 15 years and older who are at risk of developing cervical cancer. Cervical cancer ranks as the 1st most frequent cancer among women in India. Current estimates indicate that every year 134,420 women are diagnosed with cervical cancer and 72,825 die from the disease. Cervical cancer has the highest rate of cancer incidence & mortality among Indian women. Cancer starts with infection with HPV and then persistence of infection leads onto preinvasive lesion and after 10-15 years into invasive cervical cancer. The development of cervical cancer is typically slow, and occurs over a period of years. The progression to cervical cancer begins with the development of precancerous changes in normal cells. Most of these changes, even if left untreated, will not progress to cancer. There are several risk factors for the development of cervical cancer, both genetic and environmental. These include: Human Papillomavirus (HPV) Infection, Family History of Cervical Cancer, Age, Sexual and Reproductive History, Socioeconomic Status, Smoking, HIV Infection, long-term use of oral contraceptives, >99% of Cervical Cancer cases are attributed to HPV infection - World Cancer Congress 2012. Although cancer of the cervix can develop in women of all ages, it usually develops in women aged 35-55 years, with the peak age for incidence varying with populations (Zeller et al, 2007). In India, the peak age for cervical cancer incidence is 45-54 years, which is similar to the rest of South Asia [WHO/ICO Information Centre on HPV and Cervical Cancer (a)].
Manu Noatay is Laboratory Director and Principal Consultant, Niche Theranostics and Co- founder of Niche Foundation, Lab Medicine Expert (M.B.B.S.) & (M.D.) with rich experience in Medical/laboratory Operations and Clinical Research. Dr. Manu Noatay is a Keen Cytopathologist and currently working with various agencies like FPAI, FOGSI and Parivar Sanstha along with key opinion leaders in Gynecology in field of cervical pre-cancer detection with help of latest FDA approved technologies. She has completed her M.D. (Pathology) from Army Hospital Research & Referral, New Delhi (Delhi University), M.B.B.S. from I.G.M.C., Shimla (H.P. University). Fellowship of International Academy of Cytology. She is also a Member of IAPM, Member of British Society of Clinical Cytology, Fellow of International Academy of Cytopathology and Renal Pathology Society. Dr. Manu Noatay has wide range of experience as lab medicine expert in Apollo Clinics, Fortis Escorts and Super Religare Laboratories in past, mainly as Chief of Pathology for past 8 years. She has published papers and Presented poster and conducted workshop in various international Conferences.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version